Advertisement

Annals of Hematology

, Volume 89, Issue 11, pp 1179–1180 | Cite as

Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease

  • Niall F. Davis
  • Barry B. McGuire
  • Leo Lawlor
  • Peter O’Gorman
  • Kiaran J. O’Malley
  • John M. Fitzpatrick
Letter to the Editor

Dear Editor,

A 17-year-old Nigerian female (para 1 + 0) with sickle cell disease (genotype HbSS) presented to the emergency department in sickle crisis with a 4-day history of gross haematuria with clots. The crisis settled quickly but her haematuria continued unabated. Urine was sterile and serum creatinine was 52 mmol/L. This was her first episode of haematuria. She had no other relevant past medical or family history. For 14 days, the patient was treated with intravenous fluids, analgesia and repeated blood transfusion. She underwent a number of investigations during this time.

CT urography and angiography demonstrated bilateral papillary necrosis and thrombus within the bladder. Selective bilateral renal arteriogram showed four renal arteries but no vascular abnormality or active bleeding point. Cystoscopy was performed and thrombus was evacuated. Following administration of furosemide, a jet of blood coming from the left ureteric orifice was seen. Both ureters were catheterised...

Keywords

Sickle Cell Disease Streptokinase Tranexamic Acid Ureteral Obstruction Aminocaproic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Bennett MA, Heslop RW, Meynell MJ (1967) Massive haematuria associated with sickle-cell trait. Br Med J 1:677–679CrossRefPubMedGoogle Scholar
  2. 2.
    Mostofi FK, Vorder Brueege CF, Diggs LW (1957) Lesions in kidneys removed for unilateral hematuria in sickle-cell disease. AMA Arch Pathol 63:336–351PubMedGoogle Scholar
  3. 3.
    Lucas WM, Bullock WH (1960) Hematuria in sickle cell disease. J Urol 83:733–741PubMedGoogle Scholar
  4. 4.
    Harrow BR, Sloane JA, Liebman NC (1963) Roentgenologic demonstration of renal papillary necrosis in sickle-cell trait. N Engl J Med 268:969–976CrossRefPubMedGoogle Scholar
  5. 5.
    Immergut MA, Stevenson T (1965) The use of epsilon amino caproic acid in the control of hematuria associated with hemoglobinopathies. J Urol 93:110–111PubMedGoogle Scholar
  6. 6.
    Charytan C, Purtilo D (1969) Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N Engl J Med 280:1102–1104CrossRefPubMedGoogle Scholar
  7. 7.
    Wellington K, Wagstaff AJ (2003) Tranexamic acid: a review of its use in the management of menorrhagia. Drugs 63(13):1417–1433CrossRefPubMedGoogle Scholar
  8. 8.
    Verstraete M (1985) Clinical application of inhibitors of fibrinolysis. Drugs 29(3):236–261CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Niall F. Davis
    • 1
  • Barry B. McGuire
    • 1
  • Leo Lawlor
    • 2
  • Peter O’Gorman
    • 3
  • Kiaran J. O’Malley
    • 1
  • John M. Fitzpatrick
    • 1
  1. 1.Department of UrologyMater Misericordiae HospitalDublin 7Ireland
  2. 2.Department of RadiologyMater Misericordiae HospitalDublin 7Ireland
  3. 3.Department of HaematologyMater Misericordiae HospitalDublin 7Ireland

Personalised recommendations